Deirdre O'Brien, based in London, England, United Kingdom, is currently a Corporate Development | Head of M&A at Rosemont Pharmaceuticals, bringing experience from previous roles at Oxford Biomedica, PWC, Synapticia Ltd. and Amco (Formerly Amdipharm Mercury Ltd). Deirdre O'Brien holds a Chartered Institute for Securities and Investment. With a robust skill set that includes Microsoft Office, JavaScript, Pharmaceutical Sales, Product Launch, Strategic Planning and more, Deirdre O'Brien contributes valuable insights to the industry. Deirdre O'Brien has 4 emails on RocketReach.